Key Highlights

  • RocketDNA issued its September 2026 quarterly activities report.
  • Its xBot Recurring Revenue exceeded 50% of group revenue for the first time.
  • RocketDNA reported that its xBot software recurring revenue accounted for more than half of total quarterly revenue.

RocketDNA (ASX:RKT) changed hands at AUD 0.018 during trading on 20 November 2026, down 5.26% at that point in the session. The S&P/ASX 200 stood at 8,592.60 and the S&P/ASX 200 Information Technology index at 1,725.80 at 4:25 pm AEDT. Australian technology shares were under pressure amid a global pullback in AI-linked equities. RocketDNA works in autonomous drone systems and associated software.

September-quarter revenue performance

In its 29 October 2026 announcement, rocketDNA issued its September 2026 quarterly activities report. The company reported Q3 FY26 revenue of AUD 2.46 million, 31% above Q3 FY25. Its xBot recurring revenue exceeded 50% of group revenue for the first time.

xBot recurring software income

xBot recurring revenue rose 24% quarter on quarter. RocketDNA reported that its xBot software recurring revenue accounted for more than half of total quarterly revenue. The update described a full-quarter contribution from customers commencing services earlier in 2026.

Autonomous systems operating milestones

The company operates in automated drone systems and related software. The report discussed a full-quarter revenue contribution from customers who commenced services earlier in 2026.

About the Company

RocketDNA operates in autonomous drone systems and associated software. Its activities are carried out through the products, services and customer arrangements identified in its company reporting. Its update covered September-quarter recurring software revenue, alongside the financial measures and commercial activity detailed above.

Sector Context

Technology was among the sectors affected by broad selling on the ASX on 20 November 2026, against a global retreat in AI-related equities. The S&P/ASX 200 observation of 8,592.60 and information technology index level of 1,725.80 provide index context, but not an explanation for the individual share-price movement. The company release and the share-market movement are separate developments; the company release was dated 29 October 2026.

Risks to Watch

Factors relevant to RocketDNA include delivery of the activities described in its update, operating cash requirements, customer decisions and the timetable for commercial or project milestones. Where the company reports guidance, forecast amounts remain distinct from recognised results. Announced transactions, targets and development programs also need to be distinguished from completed outcomes. Future reports will clarify the position on any outstanding milestones.

Catalysts on Watch

The next company filings can provide updates on September-quarter recurring software revenue, including whether dated operating measures or implementation milestones have changed. New guidance, customer activity, approvals and cash-flow reports could provide the next measurable operating developments. Milestones described as planned in the release are not reported as complete until the company confirms completion.

Developments in Focus

RocketDNA’s 29 October 2026 announcement sets out the latest company-specific developments addressed here. Those disclosures relate to their own financial and operating periods, while the share-price and benchmark observations relate to trading on 20 November 2026. Further quarterly or annual reporting will show how those developments progress.